Trial intelligence / Profile preview

Scalp block for hemodynamic stability and comfort in craniotomy

NCT03177252Phase 1Withdrawn

Sponsor
Washington University School of Medicine
Start
Oct 2020
Primary completion
Sep 2021
Modality
Small Molecules
01

Overview

Phase 1, randomised, triple-blind trial of lidocaine and bupivacaine in pain and hemodynamic instability (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Overall perioperative comfort of the patient as measured by hemodynamic fluctuations at 48 hours and Overall perioperative comfort as measured by opioid requirements at 48 hours. Planned start Oct 2020; status: withdrawn.

02

Drugs

lidocainebupivacaine
03

Conditions

painhemodynamic instability

Beyond the preview

Go deeper on NCT03177252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03177252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call